Antibe Therapeutics Inc. announced that its founder, Dr. John L. Wallace, has decided to retire from the Board of Directors. Dr. Wallace will remain a corporate Vice Chair, enabling the company to continue to benefit from his wisdom and expertise.
Antibe Therapeutics Inc.
Equities
ATE
CA0370255097
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+17.73% | 123B | |
+16.88% | 111B | |
-9.04% | 23.63B | |
+4.40% | 22.58B | |
-38.15% | 17.61B | |
-7.75% | 17.6B | |
-15.36% | 17.26B | |
+3.42% | 13.55B | |
+29.63% | 11.34B |